首页> 美国卫生研究院文献>Clinical Molecular Pathology >Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.
【2h】

Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.

机译:正常女性献血者外周血单核细胞中细胞角蛋白19表达的逆转录酶-聚合酶链反应分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Early detection of haematogenous dissemination of epithelial tumours afforded by the analysis of epithelial antigen expression in the peripheral blood mononuclear fraction (PBMN) and bone marrow may confer a worse prognosis to patients with carcinoma. Cytokeratin 19 is a protein normally expressed by epithelial cells including normal and malignant mammary cells. Previous studies have demonstrated that analysis of cytokeratin 19 expression by the reverse transcriptase-polymerase chain reaction (RT-PCR) can detect one epithelial cell in as many as 10(5)-10(7) haematopoetic cells. Despite its sensitivity concern has been voiced recently about the specificity of this technique owing to the detection of cytokeratin 19 expression in the PBMN of normal volunteers and the bone marrow of patients with haematological malignancies. AIMS: To assess the sensitivity and specificity of RT-PCR detection of cytokeratin 19 in PBMN of normal female blood donors. METHODS: Blood was taken from 52 normal female blood donors and PBMN separated through Fycol gradient centrifugation. Cytokeratin 19 was measured using a two step nested RT-PCR assay. RESULTS: No amplification was found in the first step for any of the samples studied, whereas in the second step amplification was observed in 10 of the 52 samples. Both steps could detect one MCF-7 cell (the cytokeratin 19 positive control) in 10(6) CEM (cytokeratin 19 negative control) cells. CONCLUSIONS: As both PCR steps are sensitive to the 10(-6) level, performing only the first amplification step may decrease the non-specificity of this method. Further studies are needed to define the specificity and sensitivity of this technique in blood and bone marrow specimens of women with breast cancer.
机译:背景:通过对外周血单核级分(PBMN)和骨髓中上皮抗原表达的分析,早期发现上皮性肿瘤的血行播散可能会使癌症患者的预后更差。细胞角蛋白19是上皮细胞正常表达的蛋白质,包括正常和恶性乳腺细胞。先前的研究表明,通过逆转录聚合酶链反应(RT-PCR)对细胞角蛋白19表达的分析可以检测多达10(5)-10(7)个造血细胞中的一个上皮细胞。尽管它具有敏感性,但是由于检测了正常志愿者的PBMN和血液系统恶性肿瘤患者的骨髓中的细胞角蛋白19表达,最近已对该技术的特异性表示关注。目的:评估正常女性献血者PBMN中细胞角蛋白19的RT-PCR检测的敏感性和特异性。方法:从52名正常女性献血者中抽取血液,并通过Fycol梯度离心分离PBMN。使用两步嵌套式RT-PCR测定法测定细胞角蛋白19。结果:在第一步研究中没有发现扩增的样品,而在第二步中,在52个样品中有10个观察到扩增。这两个步骤都可以在10(6)个CEM(细胞角蛋白19阴性对照)细胞中检测到一个MCF-7细胞(细胞角蛋白19阳性对照)。结论:由于两个PCR步骤均对10(-6)水平敏感,因此仅执行第一个扩增步骤可能会降低该方法的非特异性。需要进一步的研究来确定这种技术在乳腺癌女性血液和骨髓标本中的特异性和敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号